Efficacy of a CBT Self-Help App (Zemedy) Versus an Education, Relaxation, and Mindfulness App for IBS: Results from Post-Treatment, 3-Month, and 6-Month Follow-Up.

IF 2.8 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Melissa Hunt, Anika Dalvie, Simay Ipek, Sophia Glinski, Riley Macks
{"title":"Efficacy of a CBT Self-Help App (Zemedy) Versus an Education, Relaxation, and Mindfulness App for IBS: Results from Post-Treatment, 3-Month, and 6-Month Follow-Up.","authors":"Melissa Hunt, Anika Dalvie, Simay Ipek, Sophia Glinski, Riley Macks","doi":"10.1097/MCG.0000000000002164","DOIUrl":null,"url":null,"abstract":"<p><strong>Goals: </strong>To test the efficacy of a self-help cognitive behavioral therapy (CBT) for irritable bowel syndrome (IBS) app compared with an active control app.</p><p><strong>Background: </strong>IBS is a disorder of gut-brain interaction that can result in significant distress, disability, and psychiatric co-morbidity. CBT is an effective treatment for IBS. Self-help CBT apps can increase accessibility but should be tested against active controls.</p><p><strong>Methods: </strong>This randomized controlled trial (NCT04665271) compared a CBT for IBS self-help app (Zemedy) to an active education, lifestyle management, relaxation, and mindfulness control app. A total of 453 individuals were screened in and offered allocation to treatment. Participants who actually downloaded their assigned app (N=267) were evenly split between the CBT app (N=136) and the active control (N=131). Follow-up data (CBT N=74, control N=82) were collected immediately post-treatment, at which point the control group was offered crossover to CBT. Follow-up data were collected at 3 (N=65) and 6 (N=32) months. Primary outcomes included IBS symptom severity and IBS quality of life. Secondary outcomes included catastrophizing, visceral anxiety, fear of food, and depression.</p><p><strong>Results: </strong>At post-treatment, the CBT group improved significantly across all outcomes. The control group also improved on all outcomes except fear of food. In the intent-to-treat analysis the CBT group improved significantly more than the control group on both primary and secondary outcomes except depression. Gains were maintained at 3 and 6 months, although attrition was considerable.</p><p><strong>Conclusion: </strong>Self-help CBT for IBS may be effective and can be delivered successfully through apps, although we did not have data on engagement. Psychoeducation about symptom management strategies, relaxation, and mindfulness are active treatment components, but CBT is better at addressing underlying maintaining factors like catastrophizing, visceral anxiety, and fear of food.</p>","PeriodicalId":15457,"journal":{"name":"Journal of clinical gastroenterology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MCG.0000000000002164","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Goals: To test the efficacy of a self-help cognitive behavioral therapy (CBT) for irritable bowel syndrome (IBS) app compared with an active control app.

Background: IBS is a disorder of gut-brain interaction that can result in significant distress, disability, and psychiatric co-morbidity. CBT is an effective treatment for IBS. Self-help CBT apps can increase accessibility but should be tested against active controls.

Methods: This randomized controlled trial (NCT04665271) compared a CBT for IBS self-help app (Zemedy) to an active education, lifestyle management, relaxation, and mindfulness control app. A total of 453 individuals were screened in and offered allocation to treatment. Participants who actually downloaded their assigned app (N=267) were evenly split between the CBT app (N=136) and the active control (N=131). Follow-up data (CBT N=74, control N=82) were collected immediately post-treatment, at which point the control group was offered crossover to CBT. Follow-up data were collected at 3 (N=65) and 6 (N=32) months. Primary outcomes included IBS symptom severity and IBS quality of life. Secondary outcomes included catastrophizing, visceral anxiety, fear of food, and depression.

Results: At post-treatment, the CBT group improved significantly across all outcomes. The control group also improved on all outcomes except fear of food. In the intent-to-treat analysis the CBT group improved significantly more than the control group on both primary and secondary outcomes except depression. Gains were maintained at 3 and 6 months, although attrition was considerable.

Conclusion: Self-help CBT for IBS may be effective and can be delivered successfully through apps, although we did not have data on engagement. Psychoeducation about symptom management strategies, relaxation, and mindfulness are active treatment components, but CBT is better at addressing underlying maintaining factors like catastrophizing, visceral anxiety, and fear of food.

CBT自助应用程序(Zemedy)与教育、放松和正念应用程序对IBS的疗效:治疗后、3个月和6个月随访的结果
目的:测试自助认知行为疗法(CBT)治疗肠易激综合征(IBS)应用程序与主动对照应用程序的疗效。背景:肠易激综合征是一种肠-脑相互作用紊乱,可导致严重的痛苦、残疾和精神合并症。CBT是治疗肠易激综合征的有效方法。自助CBT应用程序可以增加可访问性,但应该针对主动控制进行测试。方法:这项随机对照试验(NCT04665271)比较了针对IBS自助应用程序(Zemedy)的CBT与积极教育、生活方式管理、放松和正念控制应用程序。共有453人被筛选并分配到治疗中。实际下载了指定应用程序的参与者(N=267)被平均分为CBT应用程序(N=136)和主动控制(N=131)。治疗后立即收集随访数据(CBT N=74,对照组N=82),此时对照组接受CBT交叉治疗。随访时间分别为3个月(N=65)和6个月(N=32)。主要结局包括IBS症状严重程度和IBS生活质量。次要结果包括灾难化、内在焦虑、对食物的恐惧和抑郁。结果:在治疗后,CBT组在所有结果上都有显著改善。除了对食物的恐惧外,对照组的所有结果都有所改善。在意向治疗分析中,除抑郁外,CBT组在主要和次要结局上的改善显著高于对照组。在3个月和6个月时,收益保持不变,尽管损耗相当大。结论:尽管我们没有关于参与的数据,但自助CBT治疗IBS可能是有效的,并且可以通过应用程序成功交付。关于症状管理策略、放松和正念的心理教育是积极的治疗成分,但CBT更擅长解决潜在的维持因素,如灾难化、内在焦虑和对食物的恐惧。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of clinical gastroenterology
Journal of clinical gastroenterology 医学-胃肠肝病学
CiteScore
5.60
自引率
3.40%
发文量
339
审稿时长
3-8 weeks
期刊介绍: Journal of Clinical Gastroenterology gathers the world''s latest, most relevant clinical studies and reviews, case reports, and technical expertise in a single source. Regular features include cutting-edge, peer-reviewed articles and clinical reviews that put the latest research and development into the context of your practice. Also included are biographies, focused organ reviews, practice management, and therapeutic recommendations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信